These ASX shares can rise 25% to 100%+

Analysts think these shares could deliver big returns for investors.

| More on:
A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for big returns for your investment portfolio?

If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts.

Here's what you need to know about them:

AVITA Medical Inc (ASX: AVH)

Morgans sees huge upside for this ASX share over the next 12 months. In fact, the broker believes the regenerative medicine company could more than double in value from current levels.

It was very pleased with news that the US FDA has approved its Recell Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects. It commented:

AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians. We have made no changes to our forecasts and recommendation.

Morgans has an add rating and $6.40 price target on its shares. This implies potential upside of 115% for investors.

Champion Iron Ltd (ASX: CIA)

Analysts at Goldman Sachs think that this miner would be a great option for investors that are looking for exposure to iron ore. The broker feels its shares are undervalued at the current level and could offer major upside potential and good dividend yields. It said:

Supportive Valuation: the stock is trading at 0.8x NAV (A$8.8/sh) and ~4.4x EBITDA (NTM). Our NAV is based on a long run Fe price of ~US$105/t (real) for 65% Fe and ~US$75/t premium for DRPF above 62% Fe Index. For every ~US$10/t increase in our long run price, our CIA NAV would increase by ~A$1.5/sh.

Goldman has a buy rating and $8.80 price target on its shares. This implies potential upside of 25% for investors. In addition, it is forecasting dividend yields of 4% in FY 2025 and 6% in FY 2026.

Eagers Automotive Ltd (ASX: APE)

Another ASX share that could offer big returns is Eagers Automative. It operates one of Australia's largest auto dealership networks.

Bell Potter thinks that the company's shares have been oversold following a disappointing trading update last month. It said:

We believe this is a relatively isolated event that doesn't materially change the outlook so our investment thesis remains intact. We believe the stock looks value on a 2025 PE ratio of c.10x and a forecast yield of c.6% in 2024 and c.7% in 2025.

Its analysts have a buy rating and $13.35 price target on its shares. This implies potential upside of 32% for investors. In addition, dividend yields of 6%+ are forecast through to FY 2026.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical and Goldman Sachs Group. The Motley Fool Australia has recommended Avita Medical and Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Broker Notes

This speculative ASX stock could almost double in value

Bell Potter thinks investors could almost double their money with this high risk option.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

This ASX 200 stock's 'compelling valuation' makes it a strong buy

Goldman Sachs thinks a 50% return could be on the cards for investors.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX shares could rise 25% to ~50%

Big returns could await buyers of these shares according to analysts.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

rising asx share price represented by man with arms raised against blackboard featuring images of dollar notes
Broker Notes

Why these 3 ASX 200 shares just earned substantial broker upgrades

Top brokers just increased their share price forecasts for these three ASX 200 shares. But why?

Read more »

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today
Broker Notes

See why this broker just upgraded South32 shares to a buy

Commodity prices continue to create tailwinds for ASX stocks.

Read more »